| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 97 |
| 1 | RISANKIZUMAB-RZAA | 59 |
| 2 | ETANERCEPT | 41 |
| 3 | PANCRELIPASE | 36 |
| 4 | UPADACITINIB | 27 |
| 5 | ERGOCALCIFEROL | 26 |
| 6 | GABAPENTIN | 25 |
| 7 | OMEPRAZOLE MAGNESIUM | 25 |
| 8 | ACETAMINOPHEN | 23 |
| 9 | METHOTREXATE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMEPRAOLE, SODIUM BICARBONATE | 1 | 0.0031 |
| 1 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 2 | OMEPRAZOLE, SODIUM BICARBONATE | 2 | 0.0021 |
| 3 | INFLIXIMAB-DYYB | 7 | 0.0020 |
| 4 | XYLOMETAZOLINE HYDROCHLORIDE | 1 | 0.0018 |
| 5 | PSYLLIUM HUSK | 2 | 0.0015 |
| 6 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 7 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 8 | CABOTEGRAVIR SODIUM | 2 | 0.0012 |
| 9 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 78 |
| 1 | Interleukin-23 Antagonist [EPC] | 72 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 51 |
| 3 | Benzodiazepine [EPC] | 36 |
| 4 | Proton Pump Inhibitor [EPC] | 35 |
| 5 | Corticosteroid [EPC] | 32 |
| 6 | Janus Kinase Inhibitor [EPC] | 27 |
| 7 | Provitamin D2 Compound [EPC] | 26 |
| 8 | Insulin Analog [EPC] | 25 |
| 9 | Factor Xa Inhibitor [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Provitamin D2 Compound [EPC] | 26 | 0.0009 |
| 3 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 4 | Interleukin-23 Antagonist [EPC] | 72 | 0.0007 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 3 | 0.0004 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 8 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Nonergot Dopamine Agonist [EPC] | 6 | 0.0004 |